1. Home
  2. GKOS vs BSAC Comparison

GKOS vs BSAC Comparison

Compare GKOS & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • BSAC
  • Stock Information
  • Founded
  • GKOS 1998
  • BSAC 1977
  • Country
  • GKOS United States
  • BSAC Chile
  • Employees
  • GKOS N/A
  • BSAC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • BSAC Commercial Banks
  • Sector
  • GKOS Health Care
  • BSAC Finance
  • Exchange
  • GKOS Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • GKOS 8.4B
  • BSAC 9.0B
  • IPO Year
  • GKOS 2015
  • BSAC 1994
  • Fundamental
  • Price
  • GKOS $156.36
  • BSAC $19.06
  • Analyst Decision
  • GKOS Strong Buy
  • BSAC Hold
  • Analyst Count
  • GKOS 13
  • BSAC 3
  • Target Price
  • GKOS $147.23
  • BSAC $21.33
  • AVG Volume (30 Days)
  • GKOS 662.3K
  • BSAC 167.9K
  • Earning Date
  • GKOS 02-19-2025
  • BSAC 02-07-2025
  • Dividend Yield
  • GKOS N/A
  • BSAC 3.97%
  • EPS Growth
  • GKOS N/A
  • BSAC 73.04
  • EPS
  • GKOS N/A
  • BSAC 0.00
  • Revenue
  • GKOS $360,347,000.00
  • BSAC $2,100,054,993.00
  • Revenue This Year
  • GKOS $22.69
  • BSAC N/A
  • Revenue Next Year
  • GKOS $26.76
  • BSAC $6.71
  • P/E Ratio
  • GKOS N/A
  • BSAC $10.40
  • Revenue Growth
  • GKOS 18.70
  • BSAC 41.31
  • 52 Week Low
  • GKOS $83.90
  • BSAC $17.73
  • 52 Week High
  • GKOS $161.13
  • BSAC $21.43
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 60.10
  • BSAC 53.50
  • Support Level
  • GKOS $142.71
  • BSAC $18.19
  • Resistance Level
  • GKOS $158.01
  • BSAC $19.14
  • Average True Range (ATR)
  • GKOS 4.96
  • BSAC 0.28
  • MACD
  • GKOS -0.16
  • BSAC 0.07
  • Stochastic Oscillator
  • GKOS 74.10
  • BSAC 88.18

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of the Santander group and majority controlled by Santander Spain. Banco Santander is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-sized companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country LATAM Chile.

Share on Social Networks: